Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Grootendorst

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|November 3, 2011
Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey dataLogan McLeod, Basil G Bereza, Minsup Shim, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2016
Clinical and microbiological epidemiology of early and late infectious complications among solid-organ transplant recipients requiring hospitalizationBassem Hamandi, Shahid Husain, Paul Grootendorst, et al.
International Journal of Health Services : Planning, Administration, Evaluation|July 25, 2018
Intellectual Property Protection and Drug Plan Coverage: Evidence From OntarioPaul Grootendorst, Minsup Shim, Adam Falconi, et al.
The Canadian Journal of Urology|September 1, 2024
A costing and health-related quality of life study of high intensity focused ultrasound in primary treatment of localized low or intermediate risk prostate cancer in OntarioBassem Toeama, Nathan Perlis, Paul Grootendorst, et al.
The American Journal of Managed Care|June 15, 2007
Effect of copayments on drug use in the presence of annual payment limitsGeorge Kephart, Chris Skedgel, Ingrid Sketris, et al.
Journal of Health Economics|September 28, 2002
The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from CanadaSule Alan, Thomas F Crossley, Paul Grootendorst, et al.
Urology Research & Practice|March 7, 2024
A Systematic Review and Meta-Analysis of the CancerBassem Toeama, Emmanuel Papadimitropoulos, Nathan Perlis, et al.
Plos One|November 2, 2023
The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptakeJavad Moradpour, Ali Shajarizadeh, Jasmine Carter, et al.
Health Policy (Amsterdam, Netherlands)|January 25, 2011
The cost of drug development: a systematic reviewSteve Morgan, Paul Grootendorst, Joel Lexchin, et al.
Medical Care|June 24, 2004
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residentsSebastian Schneeweiss, Colin Dormuth, Paul Grootendorst, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|November 3, 2011
Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey dataLogan McLeod, Basil G Bereza, Minsup Shim, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2016
Clinical and microbiological epidemiology of early and late infectious complications among solid-organ transplant recipients requiring hospitalizationBassem Hamandi, Shahid Husain, Paul Grootendorst, et al.
International Journal of Health Services : Planning, Administration, Evaluation|July 25, 2018
Intellectual Property Protection and Drug Plan Coverage: Evidence From OntarioPaul Grootendorst, Minsup Shim, Adam Falconi, et al.
The Canadian Journal of Urology|September 1, 2024
A costing and health-related quality of life study of high intensity focused ultrasound in primary treatment of localized low or intermediate risk prostate cancer in OntarioBassem Toeama, Nathan Perlis, Paul Grootendorst, et al.
The American Journal of Managed Care|June 15, 2007
Effect of copayments on drug use in the presence of annual payment limitsGeorge Kephart, Chris Skedgel, Ingrid Sketris, et al.
Journal of Health Economics|September 28, 2002
The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from CanadaSule Alan, Thomas F Crossley, Paul Grootendorst, et al.
Urology Research & Practice|March 7, 2024
A Systematic Review and Meta-Analysis of the CancerBassem Toeama, Emmanuel Papadimitropoulos, Nathan Perlis, et al.
Plos One|November 2, 2023
The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptakeJavad Moradpour, Ali Shajarizadeh, Jasmine Carter, et al.
Health Policy (Amsterdam, Netherlands)|January 25, 2011
The cost of drug development: a systematic reviewSteve Morgan, Paul Grootendorst, Joel Lexchin, et al.
Medical Care|June 24, 2004
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residentsSebastian Schneeweiss, Colin Dormuth, Paul Grootendorst, et al.
Pageof 8